198 related articles for article (PubMed ID: 32467507)
1. Novel Anti-Hexokinase 1 Antibodies Are Associated With Poor Prognosis in Patients With Primary Biliary Cholangitis.
Reig A; Norman GL; Garcia M; Shums Z; Ruiz-Gaspà S; Bentow C; Mahler M; Romera MA; Vinas O; Pares A
Am J Gastroenterol; 2020 Oct; 115(10):1634-1641. PubMed ID: 32467507
[TBL] [Abstract][Full Text] [Related]
2. Anti-kelch-like 12 and anti-hexokinase 1: novel autoantibodies in primary biliary cirrhosis.
Norman GL; Yang CY; Ostendorff HP; Shums Z; Lim MJ; Wang J; Awad A; Hirschfield GM; Milkiewicz P; Bloch DB; Rothschild KJ; Bowlus CL; Adamopoulos IE; Leung PS; Janssen HJ; Cheung AC; Coltescu C; Gershwin ME
Liver Int; 2015 Feb; 35(2):642-51. PubMed ID: 25243383
[TBL] [Abstract][Full Text] [Related]
3. Detection of anti-kelch-like 12 and anti-hexokinase 1 antibodies in primary biliary cholangitis patients in China.
Liu ZY; Xu L; Liu B
Rev Esp Enferm Dig; 2021 Aug; 113(8):585-590. PubMed ID: 33307711
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a novel extended automated particle-based multi-analyte assay for the detection of autoantibodies in the diagnosis of primary biliary cholangitis.
Villalta D; Seaman A; Tiongson M; Warren C; Bentow C; Bizzaro N; Alessio MG; Porcelli B; Norman GL; Mahler M
Clin Chem Lab Med; 2020 Aug; 58(9):1499-1507. PubMed ID: 32286240
[TBL] [Abstract][Full Text] [Related]
5. The Prevalence of Anti-Hexokinase-1 and Anti-Kelch-Like 12 Peptide Antibodies in Patients With Primary Biliary Cholangitis Is Similar in Europe and North America: A Large International, Multi-Center Study.
Norman GL; Reig A; Viñas O; Mahler M; Wunsch E; Milkiewicz P; Swain MG; Mason A; Stinton LM; Aparicio MB; Aldegunde MJ; Fritzler MJ; Parés A
Front Immunol; 2019; 10():662. PubMed ID: 31001269
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic significance of autoantibodies in patients with primary biliary cirrhosis].
Xiao H; Chen JW; Xie X; Liu YM; Li F
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 44(2):209-14. PubMed ID: 22516989
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of primary biliary cirrhosis and disease-associated autoantibodies in Japanese patients with systemic sclerosis.
Imura-Kumada S; Hasegawa M; Matsushita T; Hamaguchi Y; Encabo S; Shums Z; Norman GL; Takehara K; Fujimoto M
Mod Rheumatol; 2012 Nov; 22(6):892-8. PubMed ID: 22327744
[TBL] [Abstract][Full Text] [Related]
8. The antinuclear autoantibodies Sp100 and gp210 persist after orthotopic liver transplantation in patients with primary biliary cirrhosis.
Luettig B; Boeker KH; Schoessler W; Will H; Loges S; Schmidt E; Worman HJ; Gershwin ME; Manns MP
J Hepatol; 1998 May; 28(5):824-8. PubMed ID: 9625318
[TBL] [Abstract][Full Text] [Related]
9. Primary biliary cirrhosis-related autoantibodies in a large cohort of italian patients with systemic sclerosis.
Cavazzana I; Ceribelli A; Taraborelli M; Fredi M; Norman G; Tincani A; Satoh M; Franceschini F
J Rheumatol; 2011 Oct; 38(10):2180-5. PubMed ID: 21921093
[TBL] [Abstract][Full Text] [Related]
10. Treatment of primary biliary cholangitis with ursodeoxycholic acid, prednisolone and immunosuppressants in patients not responding to ursodeoxycholic acid alone and the prognostic indicators.
Qian JD; Yao TT; Wang Y; Wang GQ
Clin Res Hepatol Gastroenterol; 2020 Nov; 44(6):874-884. PubMed ID: 32305248
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic accuracy of biomarkers for diagnosis of primary biliary cholangitis (PBC) in anti-mitochondrial antibody (AMA)-negative PBC patients: a review of literature.
de Liso F; Matinato C; Ronchi M; Maiavacca R
Clin Chem Lab Med; 2017 Nov; 56(1):25-31. PubMed ID: 28731850
[TBL] [Abstract][Full Text] [Related]
12. PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis.
Liu H; Norman GL; Shums Z; Worman HJ; Krawitt EL; Bizzaro N; Vergani D; Bogdanos DP; Dalekos GN; Milkiewicz P; Czaja AJ; Heathcote EJ; Hirschfield GM; Tan EM; Miyachi K; Bignotto M; Battezzati PM; Lleo A; Leung PS; Podda M; Gershwin ME; Invernizzi P
J Autoimmun; 2010 Dec; 35(4):436-42. PubMed ID: 20932720
[TBL] [Abstract][Full Text] [Related]
13. Presence of anti-gp210 or anti-sp100 antibodies in AMA-positive patients may help support a diagnosis of primary biliary cholangitis.
Jaskowski TD; Nandakumar V; Novis CL; Palmer M; Tebo AE
Clin Chim Acta; 2023 Feb; 540():117219. PubMed ID: 36610465
[TBL] [Abstract][Full Text] [Related]
14. Antimitochondrial antibody-negative primary biliary cirrhosis: a subset of primary biliary cirrhosis.
Liu B; Shi XH; Zhang FC; Zhang W; Gao LX
Liver Int; 2008 Feb; 28(2):233-9. PubMed ID: 18251980
[TBL] [Abstract][Full Text] [Related]
15. Fluctuations of antimitochondrial antibodies and anti-gp210 antibody in a patient with primary biliary cholangitis and Sjögren syndrome with subsequent autoimmune hemolytic anemia: A case report.
Zhao DT; Liu YM; Han Y; Zhang HP; Zhao Y; Yan HP
Medicine (Baltimore); 2020 Jan; 99(3):e18856. PubMed ID: 32011506
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis assessment of GP210 and SP100 for the diagnosis of primary biliary cirrhosis.
Hu SL; Zhao FR; Hu Q; Chen WX
PLoS One; 2014; 9(7):e101916. PubMed ID: 25010534
[TBL] [Abstract][Full Text] [Related]
17. Overcoming a "probable" diagnosis in antimitochondrial antibody negative primary biliary cirrhosis: study of 100 sera and review of the literature.
Bizzaro N; Covini G; Rosina F; Muratori P; Tonutti E; Villalta D; Pesente F; Alessio MG; Tampoia M; Antico A; Platzgummer S; Porcelli B; Terzuoli L; Liguori M; Bassetti D; Brusca I; Almasio PL; Tarantino G; Bonaguri C; Agostinis P; Bredi E; Tozzoli R; Invernizzi P; Selmi C
Clin Rev Allergy Immunol; 2012 Jun; 42(3):288-97. PubMed ID: 21188646
[TBL] [Abstract][Full Text] [Related]
18. Clinical performance of AMA-M2, anti-gp210 and anti-sp100 antibody levels in primary biliary cholangitis: When detected by multiplex bead-based flow fluorescent immunoassay.
Wang Z; Li Y; Ren L; Li Y; Xu T; Li W; Gao W; Sun G; Liu M
Immun Inflamm Dis; 2024 Jan; 12(1):e1161. PubMed ID: 38270327
[TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of combined anti-mitochondrial M2 detection assays for primary biliary cirrhosis.
Han E; Jo SJ; Lee H; Choi AR; Lim J; Jung ES; Oh EJ
Clin Chim Acta; 2017 Jan; 464():113-117. PubMed ID: 27864100
[TBL] [Abstract][Full Text] [Related]
20. [Clinical manifestation and autoantibody profile in 123 patients with primary biliary cirrhosis].
Liu HH; Fu JL; Xu J; Luo SQ; Liu ZW; Wang FS
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):233-7. PubMed ID: 23591343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]